Radionuclide therapy · 3 steps
Lu-177 DOTATATE: targeting and kidney protection
Lu-177 DOTATATE binds SSTR2, is internalised and stays in the lysosome; β⁻ travels tens of cell diameters and irradiates neighbours too; lysine-arginine protects the kidney by reducing megalin-mediated reabsorption.
Step one shows a single tumour cell: Lu-177 DOTATATE leaves the capillary, binds the seven-transmembrane SSTR2, is internalised through a clathrin-coated pit, the receptor recycles and Lu-177 stays in the lysosome. Step two shows tissue at true scale: β tracks run across tens of cells and reach cells without receptors. Step three shows glomerular filtration and megalin-mediated reabsorption in the proximal tubule, compared with lysine-arginine.
Lu-177 DOTATATE binds SSTR2, is internalised and stays in the lysosome; β⁻ travels tens of cell diameters and irradiates neighbours too; lysine-arginine protects the kidney by reducing megalin-mediated reabsorption.
Source: book 26.4 (EANM); SSTR2 internalisation Reubi 2003 (Endocr Rev), Cescato 2006 (J Nucl Med); megalin-mediated reabsorption de Jong 2005, Vegt 2010 (J Nucl Med); β spectrum ENSDF, ranges NIST ESTAR (water). Timing and reabsorption probabilities representative.
How to use: a single click on the drawing pauses and resumes; in the third step ↑ ↓ or the buttons below switch the amino acid infusion on and off; ← → change steps.
Presentation mode ↗The animation alone, sized for full screen; for projecting in lectures and talks. ← → step, space plays/pauses.
Embed
Paste this code into your own page (course site, slides, learning platform). The animation arrives working, with its source written underneath.
In the book
In the book this animation runs in place of these figures: